Comparing Analgesic effect of 808nm low-level laser, dry needing and cupping in the treatment of MPDS
Not Applicable
Recruiting
- Conditions
- myofascial trigger points pain syndrome.
- Registration Number
- IRCT20111121008146N38
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Age over 18 years
The presence of a trigger point in the temporalis or master or external trigeminal muscles that are identified by touch and examination
Exclusion Criteria
Taking painkillers, muscle relaxants, anti-inflammatory drugs and benzodiazepines
Fear of needles, cupping or lasers
Bleeding disorders
Any underlying diseases such as metabolic (diabetes) and vascular
Neurological disorders (trigeminal neuralgia)
Pregnancy
Receive any treatment for temporomandibular joint disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: Pain is recorded in the first session of the examination under VAS 1 and then in each treatment session at the beginning of the session before the start of the new treatment phase that day in the relevant schedule. The last amount of pain recording in the follow-up session is done 1 month after the completion of the treatment sessions as VAS 2 or Visit In 1 Month. Method of measurement: Visual Analogue Scale.
- Secondary Outcome Measures
Name Time Method (Maximum mouth opening). Timepoint: In the first session, the examination is called MMO 1 and each session is recorded in the relevant table before starting the treatment. The last MMO registration in the follow-up session is done 1 month after the completion of the treatment sessions as MMO2 or Visit In 1 Mouth. Method of measurement: By calibrated ruler in mm.